# Respiratory Virus Hospitalization Study (FLU 003 Plus)

> **NCT01056185** · — · COMPLETED · sponsor: **University of Minnesota** · enrollment: 1000 (estimated)

## Conditions studied

- Influenza
- Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV)
- Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01056185
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2024-08-30
- **Final completion:** 2024-08-30
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-10-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01056185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01056185, "Respiratory Virus Hospitalization Study (FLU 003 Plus)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01056185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*